Cargando…
Intolerance to Angiotensin Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based Cohort Study
BACKGROUND: Angiotensin converting enzyme inhibitor (ACEI) intolerance commonly occurs, requiring switching to an angiotensin-II receptor blocker (ARB). Angiotensin converting enzyme inhibitor intolerance may be mediated by bradykinin, potentially affecting airway hyperresponsiveness. OBJECTIVE: To...
Autores principales: | Morales, Daniel R., Lipworth, Brian J., Donnan, Peter T., Wang, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443840/ https://www.ncbi.nlm.nih.gov/pubmed/33965593 http://dx.doi.org/10.1016/j.jaip.2021.04.055 |
Ejemplares similares
-
Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021) -
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
por: Hicks, Blánaid M, et al.
Publicado: (2018) -
Determinants of circulating angiotensin-converting enzyme 2 protein levels in the general population
por: Kuznetsova, Tatiana, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme Inhibitors and Active Tuberculosis: A Population-Based Study
por: Wu, Jiunn-Yih, et al.
Publicado: (2016) -
Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)